Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

被引：0
|
作者：
Frederik Barkhof
Peter A. Calabresi
David H. Miller
Stephen C. Reingold
机构：
[1] VU University Medical Center,Department of Radiology and Amsterdam MS Center
[2] Johns Hopkins School of Medicine,Department of Neurology
[3] Institute of Neurology,Department of Neuroinflammation and NMR Research Unit
[4] University College London,undefined
[5] National MS Society and Scientific and Clinical Review Associates,undefined
[6] LLC,undefined
来源：
Nature Reviews Neurology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Multiple sclerosis is traditionally considered to be an inflammatory disease, but it also has a neurodegenerative component, which can manifest early in the disease course. New therapeutic strategies are being developed to elicit CNS neuroprotection and repair in patients with multiple sclerosis, and Barkhof et al. review the available data on imaging outcome measures that could be used to track the efficacy of these approaches.
引用
收藏
页码：256 / 266
页数：10
相关论文
共 50 条
  • [1] Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
    Barkhof, Frederik
    Calabresi, Peter A.
    Miller, David H.
    Reingold, Stephen C.
    [J]. NATURE REVIEWS NEUROLOGY, 2009, 5 (05) : 256 - 266
  • [2] Neuroprotection and repair in multiple sclerosis
    Robin J. M. Franklin
    Charles ffrench-Constant
    Julia M. Edgar
    Kenneth J. Smith
    [J]. Nature Reviews Neurology, 2012, 8 : 624 - 634
  • [3] Neuroprotection and repair in multiple sclerosis
    Franklin, Robin J. M.
    Ffrench-Constant, Charles
    Edgar, Julia M.
    Smith, Kenneth J.
    [J]. NATURE REVIEWS NEUROLOGY, 2012, 8 (11) : 624 - 634
  • [4] Imaging outcomes for trials of remyelination in multiple sclerosis
    Mallik, Shahrukh
    Samson, Rebecca S.
    Wheeler-Kingshott, Claudia A. M.
    Miller, David H.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (12): : 1396 - 1404
  • [5] MRI measures of neuroprotection and repair in multiple sclerosis
    Inglese, Matilde
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 311 : S16 - S23
  • [6] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Sormani, Maria Pia
    Pardini, Matteo
    [J]. NEUROTHERAPEUTICS, 2017, 14 (04) : 924 - 933
  • [7] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Maria Pia Sormani
    Matteo Pardini
    [J]. Neurotherapeutics, 2017, 14 : 924 - 933
  • [8] Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis
    Loeb, Jeffrey A.
    [J]. NEUROLOGY, 2007, 68 : S38 - S42
  • [9] New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis
    Villoslada, Pablo
    Steinman, Lawrence
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (05) : 443 - 459
  • [10] Neuroprotection in multiple sclerosis
    Waxman, SG
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (09) : 1145 - 1145
12345